The patent-pending technology behind WoundStat is the result of more than three years of research and development by VCURES. The university center not only conducts research on life-saving technologies, it plays a key role in training Special Operation Combat Medics in the U.S. military. TraumaCure anticipates that WoundStat will be available for deployment by the late fall. Both U.S. military and foreign military allies have expressed interest in the new product.
"WoundStat's value goes beyond the battlefield," said retired Lieutenant General Ronald Blanck, DO, former Surgeon General of the Army. "It will provide a life-saving tool in everyday civilian emergency situations as well as where advanced medical care is not immediately available, such as accidents in remote terrain and on the high seas, or in unexpected disasters such as earthquakes or explosions."
TraumaCure is continuing research for discovery and development of additional products based on the core compounds used in WoundStat. The current focus is on trauma injury care, and future products will aim at surgical, chronic wound, and burn care.
For additional information and interview requests please contact Sanda Pecina (202-367-1622, firstname.lastname@example.org.)
The mission of TraumaCure's team of seasoned life science, healthcare, and medical device professionals is to develop life-saving wound treatment products that can be used by everyone, ranging from the military to medical personnel to civilians, when there is traumatic injury, surgery, or similar need. The company is based in Bethesda, MD, and was founded in 2006. WoundStat(TM) is its first product.
About VCU and th
|SOURCE TraumaCure Inc.|
Copyright©2007 PR Newswire.
All rights reserved